ABSTRACT PURPOSE: To evaluate the clinical outcomes of custom topographic neutralizing technique in treating highly aberrated eyes using the WaveLight ALLEGRETTO WAVE Excimer Laser.
METHODS:
A retrospective consecutive case series of 67 eyes with decentered ablations and 48 eyes with symptomatic small optical zones after previous LASIK underwent topography-guided retreatment with the ALLEGRETTO WAVE. Sixteen keratoconus eyes underwent topographic neutralizing technique photorefractive keratectomy (PRK). The study assessed preoperative and 6-month and 1-year postoperative results regarding best spectacle-corrected visual acuity (BSCVA), uncorrected visual acuity (UCVA), topography, and predictability.
RESULTS:
Sixty-seven eyes with previously decentered optical zones had an improvement of centration from 0.92 mm preoperatively to 0.30 mm postoperatively relative to pupil center (PϽ.01). Twenty-nine percent of these eyes gained 1 or more lines of BSCVA, whereas 71% had no change in BSCVA. Forty-eight eyes with previously small optical zones had an increase of the central monodioptric optical zone from 3.9 mm to 5.6 mm (PϽ.01). Nineteen percent of eyes had an improvement of at least 1 line, whereas 75% had no change in BSCVA and 6% lost 1 line. Sixteen keratoconus eyes had custom topographic neutralizing technique PRK as an alternative to penetrating keratoplasty. All eyes had improvement of astigmatism up to 5.00 diopters (D), with a mean change of 1.68Ϯ1.62 D. Best spectaclecorrected visual acuity was unchanged in 8 (50%) eyes, with 4 (25%) eyes gaining 1 line, 2 (12%) eyes gaining 2 lines, and 2 (12%) eyes losing 1 line of BSCVA at 6 months.
CONCLUSIONS: Management of some highly aberrated eyes is now possible with topography-guided ablation using the WaveLight ALLEGRETTO platform and custom topographic neutralizing technique. Safety was acceptable for small optical zone and decentered ablation retreatments. The topography-guided ablation could be an alternative treatment for keratoconus patients if keratoplasty is otherwise indicated. T opographic-guided laser ablation attempts to neutralize and preserve the aspheric shape of the cornea and has been described as a new tool for the treatment of highly aberrated eyes. The excimer laser ablation based on corneal topography is less dependent on intraocular physiologic changes and can be used to treat irregular corneas even in cases where it is not possible to obtain reproducible wavefront measurements.
Custom topographic neutralizing technique is a method developed to optimize topographic-guided treatments of aberrated eyes with the ALLEGRETTO WAVE (WaveLight AG, Erlangen, Germany). Custom topographic neutralizing technique helps adjust for the induced refractive change of surface regularization from topography-guided treatments.
Topographic-guided ablation with the WaveLight ALLEGRETTO incorporates the ALLEGRETTO WAVE Topolyzer with the T-CAT software for treatment. 1 The Topolyzer is a 20-ring topographer that uses up to 22,000 points to map the surface. As the topographer does not give any refractive data, the patient's refraction has to be adjusted based on the surface irregularity being corrected. Custom topographic neutralizing technique was developed to help improve refractive predictability and can be used to treat aberrated eyes, including enlargement of small optical zones, correction of decentered optical zones, and for the primary treatment of asymmetrical astigmatism.
The ALLEGRETTO laser incorporates the Q-value assisted treatment mode to improve the corneal aspheric profi le, allowing prediction of the fi nal corneal asphericity. Adjustment of the different ablation patterns is possible using this plat-
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Topography-guided Ablation in Highly Aberrated Eyes/Lin et al form. Topography-guided ablation offers a potential treatment for symptomatic, postoperative refractive surgical retreatments, keratoconus eyes, and corneal irregularities, such as astigmatism after keratoplasty.
The purpose of this study is to evaluate the results of custom topographic neutralizing technique in aberrated eyes, including enlargement of small optical zones, decentered ablation, and keratoconus eyes using the ALLEGRETTO WAVE Excimer Laser. (Table) . The decentered ablation group and small optic zone group underwent topography-guided LASIK retreatment by fl ap lift with the ALLEGRETTO WAVE. The study compared preoperative, 6-month, and 1-year results, looking specifi cally at the topographic central monodioptric optical zone, best spectacle-corrected visual acuity (BSCVA), uncorrected visual acuity (UCVA), and predictability of refraction. 
PATIENTS AND METHODS

UCVA = uncorrected visual acuity, BSCVA = best spectacle-corrected visual acuity, Q-value = asphericity
Topography-guided Ablation in Highly Aberrated Eyes/Lin et al
The keratoconus group comprised 16 keratoconus eyes that were on a corneal transplant list and had a BSCVA of 20/40 or better. All eyes were contact lensintolerant, and residual corneal thickness was at least 300 µm of stroma. In all cases, the topography examinations were reproducible with an ALLEGRETTO Topolyzer. Mean preoperative astigmatism was 2.56Ϯ0.34 D, keratometry 47.7Ϯ3.22 D, and pachymetry 0.475Ϯ0.60 mm.
Symptoms were evaluated by patient history before and 6 months after surgery as obtained by chart review. Symptoms were reported as blurred or hazy vision, halos and starbursts, poor night vision, image doubling, and glare.
SURGICAL TECHNIQUE
Laser ablation was performed using custom topographic neutralizing technique in all cases by two surgeons (D.L., S.H.). Custom topographic neutralizing technique planning involves four steps.
Step 1 is to analyze the plano treatment produced by the T-CAT software for smoothing the cornea. The plano treatment is produced by the Topolyzer when no refractive input is entered, which, in an eye undergoing optical zone enlargement, is essentially an asymmetrical hyperopic treatment.
Step 2 identifi es the cylinder induced by the plano treatment and the amount of astigmatic treatment needed for neutralization.
Step 3 adds a myopic treatment in the center to compensate for the initial hyperopic ablation. In step 4, the manifest refraction is added to calculate the fi nal treatment (Fig 1) .
All cases of LASIK retreatment for the decentered ablation and small optic zone groups involved lifting the fl ap. Using topical anesthesia (proparacaine 0.5%, Alcaine; Alcon Laboratories Inc, Ft Worth, Tex), the temporal fl ap edge was marked at the slit lamp with a 30-gauge needle at one spot as the fl ap edge is usually diffi cult to visualize under the laser microscope. The patient was then positioned under the laser microscope and the fl ap edge lifted with a Sinskey hook. A Suarez spatula was then used to lift the entire fl ap at the edges to the hinge. A cyclodialysis spatula was introduced at the hinge, and the fl ap adhesions broken away from the hinge. The fl ap was fully lifted and the topographyguided ablation performed. After the ablation, 70% ethanol in balanced saline solution (BSS) was applied to the stromal bed epithelial edges for 30 seconds and any previous stromal epithelial anomalies or ingrowth removed with a spatula. The fl ap was fl oated back in position with BSS and dried in position. A bandage contact lens (SofLens 66; Bausch & Lomb, Rochester, NY) was placed overnight in all cases.
Patients with keratoconus underwent transepithelial topography-guided photorefractive keratectomy (PRK) with the ALLEGRETTO Eye-Q 400-Hz excimer laser. The topographic neutralizing technique was used to improve predictability. Mitomycin C 0.02% was instilled for 15 seconds, and a bandage contact lens was in place until full re-epithelialization. Steroids were administered for 3 months, with a tapered dosing schedule. Patients were followed for up to 12 months. Postoperatively, all eyes had UCVA 20/80 or better, with 94% 20/40 or better and 76% 20/20 or better (Fig 2) .
Additionally, 5% of eyes gained у2 lines of BSCVA, with 24% gaining 1 line and only 1% losing у1 line. Seventy-one percent of patients had no change in BSCVA. Predictability of refraction was good, with all eyes being within 2.00 D, 94% within 1.00 D, and 76% within 0.50 D of the attempted refractive outcome.
CUSTOM TOPOGRAPHY-GUIDED LASIK: OPTICAL ZONE ENLARGEMENTS
Forty-eight previously treated LASIK eyes with small optical zones underwent topography-guided LASIK retreatment, by fi rst lifting the fl ap and then undergoing laser ablation. After laser retreatment for optical zone enlargement, the mean topographic central monodioptric optical zone was 5.6 mm compared to 3.9 mm preoperatively (Fig 3) .
Postoperatively, all eyes had UCVA of 20/80 or better, with 94% 20/40 or better, 88% 20/25 or better, and 63% 20/20 or better. Nineteen percent of eyes had an improvement in BSCVA of у1 line, whereas 75% of eyes had no change in BSCVA. Additionally, 6% of eyes lost 1 line of BSCVA. The refractive outcome was found to be predictable, with all eyes being within 2.00 D, 94% within 1.00 D, and 81% within 0.50 D of attempted.
TOPOGRAPHY-GUIDED PRK FOR KERATOCONUS
Sixteen keratoconus eyes of 10 keratoconus patients with a BSCVA of 20/40 or better who were on a corneal transplant list underwent topography-guided PRK for correction of irregular astigmatism. At the last postoperative follow-up, all eyes achieved an improvement in preoperative corneal astigmatism with 50% р1.00 D, 13% between 1.00 and Ͻ2.00 D, 12% between 2.00 and 3.00 D, 19% between 4.00 and 5.00 D, and 6% Ͼ5.00 D. Astigmatism improved by a mean of 1.68Ϯ1.62 D. Eighty-eight percent of patients reported clear vision with no haze.
Preoperatively, all eyes had a BSCVA of at least 20/40, with 81% 20/30 or better, 56% 20/25 or better, and 38% 20/20 or better. The high numbers of bilateral treatments were because of the anisometropia induced from the monocular correction in these contact lens-intolerant patients. Although six of these second eye treatments had a BSCVA of 20/20, they all had topographic keratoconus and anisometropia. Postoperatively, all eyes had a BSCVA of at least 20/40, with 94% 20/30 or better, 94% 20/25 or better, and 31% 20/20 or better (Fig 4) . Fifty percent of eyes had no change in BSCVA, whereas 25% gained 1 line, 12% gained 2 lines, and 12% lost 1 line. Overall, topographic-guided PRK with custom topographic neutralizing technique was effective in reducing corneal astigmatism and irregularity in eyes with keratoconus within the fi rst year of treatment. Two (12%) eyes lost 1 line of BSCVA.
Clinical outcomes of all groups are summarized in the Table.
SYMPTOMS
All patients complained about either blurred or hazy vision, halos and starbursts, poor night vision, image doubling, or glare before surgery. At 6 months postoperative, a persistence of symptoms was reported by 19.5% of patients in the decentered ablation group, 18.7% in the small optic zone group, and 12.5% in the keratoconus group. 2-4 the correction of highly aberrated eyes remains a challenge to refractive surgery. The inability to capture reproducible centroids on wavefront maps is one of the limitations in treating eyes with highly irregular corneas. 4, 5 Topography-guided ablation does not have this limitation, and a custom topographic neutralizing technique may offer improved predictability of topography-guided LASIK and PRK. Consequently, topography-guided ablation may be a useful solution for the unhappy, symptomatic refractive surgery patient, especially among those in whom it is not possible to capture reliable wavefront maps. 4, 5 Although topography-guided ablations have been previously investigated with various laser platforms nearly a decade ago, and prior to the rise of wavefront-guided customization, 6-10 its access was never made commercially available to the average surgeon wishing to correct highly aberrated eyes. Rather wavefront-guided ablation became widely available, such that the terms "custom LASIK" and "custom PRK" are now identifi ed with wavefront rather than topographic treatment.
The equivalency of topography-guided and wavefront-guided ablation has been previously shown with the NIDEK platform (NIDEK Co Ltd, Gamagori, Japan) in virgin eyes. 11 This comparison, however, has never been made among highly aberrated retreatments, and even now both wavefront-and topography-guided methods have their limitations. The greatest criticism for wavefront customized retreatments is the lens-induced variability with age and the fact that complex retreatments depend on these factors, rather than solely on the corneal irregularity. 12 For topographic customization, the lack of predictability of the fi nal refractive . Best spectacle-corrected visual acuity (BSCVA) outcomes after topography-guided PRK for keratoconus. Of 16 eyes (10 patients), 38% had preoperative BSCVA у20/20, which decreased to 31% postoperatively; 56% had preoperative BSCVA у20/25, which increased to 94% postoperativley; 81% had preoperative BSCVA у20/30, which increased to 94% postoperatively; and 100% had pre-and postoperative BSCVA у20/40.
BSCVA
Percentage of Eyes
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Topography-guided Ablation in Highly Aberrated Eyes/Lin et al outcome is most criticized, although a recent resurgence in topography-guided retreatments with the WaveLight ALLEGRETTO laser and Topolyzer suggests that this limitation can be overcome. 13, 14 Previous studies in symptomatic eyes following refractive surgery have reported an improvement of BSCVA from a mean of 20/32 preoperatively to 20/21 postoperatively.
14 Despite this improvement, the refractive outcome may be less predictable due to the unknown spherical component of the correction that changes the refraction postoperatively.
The custom topographic neutralizing technique method of optimizing refractive outcomes is one strategy for enhancing predictability by compensating for these refractive changes associated with topography-guided ablation. Without refractive compensation, smoothening of a previously treated myopic ablation typically induces myopia as the optical zone is enlarged. This is evident in the plano topographic treatment where no refractive input is entered. By adjusting for the amount of myopia induced with custom topographic neutralizing technique, the predictability can be improved in these cases. Similarly, smoothing a decentered ablation or asymmetrical astigmatism induces refractive astigmatism as evident in the plano topographic treatment. Using custom topographic neutralizing technique to adjust for the amount of induced astigmatism in these cases should improve predictability.
With this method, aberrated eyes such as small optical zones, decentered optical zones, and irregular astigmatic corneas may be treated with improved predictability over our previous unpublished experience with topography-guided ablations when our results were similar to those reported by others. 13, 14 In our study, we have shown the fi nal refraction to be within 1.00 D of intended in 94% of eyes with both decentered and small optical zone retreatments, with more than 75% of these being within 0.50 D. Although these numbers could be improved with further refi nement, the complexity of these cases should not be underestimated. Rather these outcomes would likely rival the best predictability of complex wavefront-guided retreatments, especially without a well accepted nomogram or strategic approach.
Although our study highlights the objective fi ndings of improved outcome using the custom topographic neutralizing technique method, we attempted to retrospectively report the symptoms experienced by our patients before and after treatment. Following custom topographic neutralizing technique, only 18% of patients reported any visually disabling symptom in comparison to 100% prior to custom topographic neutralizing technique. Our impression was that many patients appreciated the improved quality of vision even in situations where there was a small residual refractive error. Our results show promise for managing symptomatic patients with decentered laser ablations and small optical zones. Evidence of topographic regularization (ie, reduced zone decentration and larger central monodioptric optical zones) and even improvements in BSCVA were seen in both groups, with few eyes showing a minimal loss of 1 line of BSCVA. The fact that 76% of the decentered eyes and 63% of the small optical zone eyes could fi nally see 20/20 or better uncorrected further gives evidence to the relative predictability of the custom topographic neutralizing technique method.
Among the keratoconus eyes, our study demonstrated that contact lens-intolerant patients awaiting corneal transplants may have an alternative with topographically directed PRK. Twenty-fi ve percent of cases gained 1 line of BSCVA, and improvement of astigmatism was observed in all cases. However, patients must have realistic expectations regarding the severity of the keratoconus and likelihood for keratometric progression. Despite our therapy, a corneal transplant is still a possibility. Custom topographic neutralizing technique improved predictability; however, expectations must remain realistic.
One new adjunct to topography-guided ablation of keratoconus is the sequential or simultaneous use of ribofl avin/UVA induced collagen crosslinking. 15 Although this combination is sequentially reported as a single case report with an excellent outcome, 15 larger series and long-term follow-up of this method are needed to validate its promising implications. A long-term study comparing keratoconus eyes undergoing topography-guided ablation with and without collagen cross-linking would be valuable and would help to fully validate this technology.
The software for topography-guided ablation currently does not compensate for the refractive change induced by topographic smoothing of irregularities. With the custom topographic neutralizing technique method of optimizing outcomes, we propose that good refractive predictability can be achieved, and have demonstrated this with a UCVA of 20/20 in 63% to 76% of eyes.
Although managing the surgical parameters of these aberrated eyes is challenging, managing the expectations of these patients may be just as challenging. Patients with aberrated eyes following refractive surgery have high expectations. Although topographyguided treatments can help, it is necessary to educate patients as to the limitations of this technology and the need for future refi nements.
